Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

2(50%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

25%

Ph early_phase_1

25%

Ph phase_1

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Early Phase 1First-in-human

1(25.0%)

Phase 1Safety & dosage

2(50.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(1)

Terminated(1)

Detailed Status

Recruiting1

Completed1

Withdrawn1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Early Phase 1

Trials by Phase

Early Phase 11 (25.0%)

Phase 12 (50.0%)

N/A1 (25.0%)

Trials by Status

recruiting125%

completed125%

withdrawn125%

active_not_recruiting125%

Recent Activity

2 active trials

Showing 4 of 4

active_not_recruitingnot_applicable

TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning

NCT05743842

recruitingphase_1

Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

NCT06432036

withdrawnphase_1

Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes

NCT05490381

completedearly_phase_1

Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion

NCT04976257

Clinical Trials (4)

Showing 4 of 4 trials

NCT05743842Not Applicable

TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning

Active Not Recruiting

NCT06432036Phase 1

Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

Recruiting

NCT05490381Phase 1

Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes

Withdrawn

NCT04976257Early Phase 1

Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion

Completed

All 4 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 4